🇺🇸 FDA
Pipeline program

Losmapimod 15 mg oral tablet

1821-CLP-101

Phase 1 small_molecule completed

Quick answer

Losmapimod 15 mg oral tablet for Healthy Adult Subjects is a Phase 1 program (small_molecule) at Fulcrum Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Fulcrum Therapeutics
Indication
Healthy Adult Subjects
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials